Clinical Trials Currently Enrolling at Banner Sun Health Research Institute

Banner Sun Health Research Institute conducts many trials and studies, but most commonly we conduct Parkinson's disease trials and Alzheimer's studies. Below is a list of some of our ongoing clinical trials. To get more information about clinical trials, please call (623) 832-6500. Other trials can also be found online at Centerwatch.com.

If you are interested participating in one of the many clinical trials at Banner Health, please complete the form here.

Parkinson's Disease Trials

• A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment (Precedent) (NCT05318937)
• A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD (Annovis) (NCT05357989)
• PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort (PPMI) (NCT04477785)
• A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80 (LUMA) (NCT05348785)
• A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (JAZZ ET) (NCT05122650)

Alzheimer's Disease Trials

• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (REFOCUS-ALZ) ( NCT05026177) 
• Escitalopram for Agitation in Alzheimer's Disease (S-CitAD) (NCT 03108846)
• TRC-PAD Program: In-Clinic Trial-Ready Cohort (TRC-PAD) (NCT 04004767)
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (NCT 04468659)
• Longitudinal Early-onset Alzheimer's Disease Study Protocol (LEADS) (NCT 03507257)
• ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease (LIFT-AD) (NCT 04488419)
• A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD (VIVA-MIND) (NCT03919162)
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) (NCT04777396)
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) (NCT04777409)
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease (ENVISION) (NCT05310071)

Lewy Body Dementia

• Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies (COG1201) (NCT05225415)